FDA Warns Parents About Benzocaine in Teething Medicines

Last updated on August 3rd, 2022 at 04:25 pm

The U.S. Food and Drug Administration (FDA) recently issued a warning to the public about the use of over-the-counter (OTC) products containing benzocaine, a local anesthetic. Benzocaine is the active ingredient in many OTC gels, sprays, liquids and lozenges used to relieve pain in the mouth and gums from a variety of conditions such as teething, canker sores, and irritation of the mouth and gums. Benzocaine use may cause methemoglobinemia, a rare, but serious, condition where the amount of oxygen that can be carried through the blood stream is greatly reduced. According to the FDA, parents and caregivers should not use benzocaine products on children under two years of age, except under the advice and supervision of a healthcare professional. For more information on the FDA’s safety announcement regarding benzocaine, click here. Parenting.com has also posted an informative blog on this topic here.

If the FDA’s recent warning has left you searching for a new teething solution, or if you’re determined to find a safer, more natural product for your baby, you may want to try Boiron’s Camilia. Our teething medicine is a one-product solution for painful gums and irritability caused by teething. Not only is Camilia benzocaine-free, it does not contain preservatives, flavors, dyes, sugar or artificial sweeteners. Its sterile single-use doses are easy to administer to children one month of age and older, and there’s no risk of overmedicating or numbing your baby’s gag reflex. Check out our store locator to find the retailer nearest you that carries Camilia.

You can stay up-to-date on issues like these and others by visiting our Camilia Facebook page or following us on Twitter.

Share article:


Related Articles:

Leave a Comment

Your email address will not be published. Required fields are marked *


Subscribe to our e-newsletter to get coupons and health tips from Boiron.
Shopping Cart